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Abstract
Background: Adverse drug reactions (ADRs) can occur any time someone uses a medication. ADRs are systematically tracked
and cataloged, with varying degrees of success, in order to better understand their etiology and develop methods of prevention.
The US Food and Drug Administration (FDA) has developed the FDA Adverse Event Reporting System (FAERS) for this purpose.
FAERS collects information from myriad sources, but the primary reporters have traditionally been medical professionals and
pharmacovigilance data from manufacturers. Recent studies suggest that information shared publicly on social media platforms
related to medication use could be of benefit in complementing FAERS data in order to have a richer picture of how medications
are actually being used and the experiences people are having across large populations.
Objective: The aim of this study is to validate the accuracy and precision of social media methodology and conduct evaluations
of Twitter ADR reporting for commonly used pharmaceutical agents.
Methods: ADR data from the 10 most prescribed medications according to pharmacy claims data were collected from both
FAERS and Twitter. In order to obtain data from FAERS, the SafeRx database, a curated collection of FAERS data, was used to
collect data from March 1, 2016, to March 31, 2017. Twitter data were manually scraped during the same time period to extract
similar data using an algorithm designed to minimize noise and false signals in social media data.
Results: A total of 40,539 FAERS ADR reports were obtained via SafeRx and more than 40,000 tweets containing the drug
names were obtained from Twitter’s Advanced Search engine. While the FAERS data were specific to ADRs, the Twitter data
were more limited. Only hydrocodone/acetaminophen, prednisone, amoxicillin, gabapentin, and metformin had a sufficient
volume of ADR content for review and comparison. For metformin, diarrhea was the side effect that resulted in no difference
between the two platforms (P=.30). For hydrocodone/acetaminophen, ineffectiveness as an ADR that resulted in no difference
(P=.60). For gabapentin, there were no differences in terms of the ADRs ineffectiveness and fatigue (P=.15 and P=.67, respectively).
For amoxicillin, hypersensitivity, nausea, and rash shared similar profiles between platforms (P=.35, P=.05, and P=.31,
respectively).
Conclusions: FAERS and Twitter shared similarities in types of data reported and a few unique items to each data set as well.
The use of Twitter as an ADR pharmacovigilance platform should continue to be studied as a unique and complementary source
of information rather than a validation tool of existing ADR databases.
(JMIR Public Health Surveill 2020;6(3):e19266) doi: 10.2196/19266
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Introduction
Background
Adverse drug reactions (ADRs) are the unintended effect of
medicine at doses used for prophylaxis, diagnosis, or treatment
[1]. ADRs can occur anytime when a patient takes a medication.
Factors including drug and food interactions, medication errors,
allergies, and metabolism contribute to the occurrence of ADRs.
ADRs have been identified as one of the leading causes of death
in the United States. ADRs resulted in more deaths than the
pulmonary diseases, diabetes, HIV/AIDS, and pneumonia [2,3].
A systematic review on ADR-induced hospital admissions found
that 5.3% of hospital admissions were associated with ADRs
[4]. New drug therapies, the aging population, and polypharmacy
expose the population to increased risks of ADRs [5]. The
burden of ADRs necessitates appropriate detection and
assessment, and reporting is fundamental to successful
pharmacovigilance systems.
The US Food and Drug Administration (FDA) Adverse Event
Reporting System (FAERS) is a database for reports of adverse
events, medication errors, and product quality complaints [6].
Although FAERS serves as a valuable data source for
postmarket pharmacovigilance, only drug manufacturers are
required to send reports received from health care professionals
and consumers to the FDA. Health care professionals and
consumers may voluntarily submit reports, which may lead to
incomplete data in FAERS. In order to obtain more
comprehensive information on drug products, multiple data
sources should be used to fill the information gap.
Social media has been proposed as a potential data source as it
allows an easily accessible information sharing platform with
almost no chronological and geographical constraints. A
systematic review of 51 studies compared ADR reports on social
media and other pharmacovigilance systems, and the review
noted that the prevalence of all ADR reports ranged from 0.2%
to 8% and social media contained more reports of mild ADRs
than severe ADRs [7]. Previous studies showed that ADRs were
underrepresented in clinical trial data, and less severe ADRs
were more frequently reported on social media. Social media
ADR reports reflected the ADRs reported on FAERS on average
11 months earlier [8,9]. Comparative studies suggested the
practicality of using social media as a complementary resource
and demonstrated a moderate agreement on ADR data between
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social media and FAERS [10,11]. These studies have shed light
on the role of social media in ADR reporting. However, many
studies only examined one or two less commonly used
pharmaceutical agents, and some included more than 1000
drugs. While the inclusion tested a general scheme of social
media reporting, it overlooked the role of social media reporting
for common drugs.
The Center for Medication Safety Advancement (CMSA) at
Purdue University College of Pharmacy aims to adopt previous
research strategies and compare ADR reports in social media
and FAERS. Twitter was selected as the social media for
evaluation thanks to its simplicity and timeliness in information
sharing and access. Twitter users can report an ADR in one
tweet pursuant to the FDA guideline, which requires as a
minimum dataset to constitute a viable report an identifiable
patient, an identifiable reporter, a product exposure, and an
adverse event [12]. Additionally, the FDA does not require
reports to demonstrate causation or to be specific regarding the
type of error. All suspected medication errors, ADRs, or adverse
events are accepted as reports. Given the advantage of the
Twitter database, the objective of this study is to validate the
accuracy and precision of the research methodology and conduct
evaluations of social media ADR reporting via tweets for
commonly used pharmaceutical agents.

Ethics Statement
All social media data used in data collection and analysis were
extracted from public sources. Example tweets were paraphrased
and edited to prevent unmasking through a reverse search on
Twitter. FAERS reports on SafeRx were also anonymized. As
data used in this study were publicly available, no institutional
review board approval was sought.

Methods
Overview
This study was divided into 3 sections: drug selection, FAERS
data collection, and Twitter data collection. Collecting FAERS
data included searching for ADR reports of a pharmaceutical
agent and calculating relative frequencies of the 5 most
frequently reported ADRs, whereas Twitter data collection
required an additional step to identify relevant tweets according
to inclusion and exclusion criteria. Figure 1 demonstrates the
overall scheme for the methodology of this study.
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Figure 1. Methodology scheme. ADR: adverse drug reaction; FAERS: FDA Adverse Event Reporting System.
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Pharmaceutical Agents
To identify the 10 most popular prescribed medications,
prescription data were used from GoodRx, a health care
company that operates a telemedicine platform. GoodRx
generates a list of the top 10 drugs from monthly claims
submitted by pharmacies in the United States; in November
2017, those drugs were hydrocodone/acetaminophen,
levothyroxine, prednisone, lisinopril, amoxicillin, gabapentin,
metformin, atorvastatin, alprazolam, and amlodipine [13].
Previous studies included both brand and generic names in data
collection to expand the data that could be obtained [10,14].
Some studies further suggested that patients tended to use the
most common brand name in social media if a drug had multiple
brand names [15,16]. Accordingly, this study included common
brand names in the searching criteria as Twitter users could be
discussing ADRs using common brand names. For the data
collection purpose of this study, the most commonly used brand
name for each selected drug was identified according to
Micromedex: Norco for hydrocodone/acetaminophen, Synthroid
for levothyroxine, Deltasone for prednisone, Prinivil for
lisinopril, Amoxil for amoxicillin, Neurontin for gabapentin,
Glucophage for metformin, Lipitor for atorvastatin, Xanax for
alprazolam, and Norvasc for amlodipine.

US Food and Drug Administration Adverse Event
Reporting System Data
Purdue University College of Pharmacy’s CMSA designed and
maintained a searchable database for all published FAERS
reports since 2012 under SafeRx. SafeRx enables large-scale
studies to improve prescription medication safety as the database
contains a collection of 4,935,048 ADRs, representing 294,652
different drugs from the fourth quarter of 2012 through
December 2016. ADR reports were obtained via the FAERS
Data Explore function in SafeRx. The search criteria were set
to display data from March 1, 2016, to March 31, 2017, and the
data included both brand and generic names of selected drugs
as the primary suspect and the secondary suspect drug. After
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obtaining all ADR reports from SafeRx, the 5 most reported
ADRs for each selected drug were recorded for data analysis.

Twitter Data
Searchability and generalizability were the main factors in
selecting Twitter as the social media platform. Twitter’s search
engine enabled keyword-based searching within a predetermined
time frame, and all public tweets containing the keyword could
be displayed. According to the Pew Research Center, Twitter
users were diverse in terms of age distribution and well balanced
in terms of gender and geographic areas at the time of study in
2016
[17].
As
medications
including
hydrocodone/acetaminophen, prednisone, levothyroxine could
be prescribed to individuals from all age groups regardless of
gender and geographic areas, Twitter’s population represented
a robust data source for generalizability.
Tweets were obtained from the Advanced Search webpage on
Twitter’s website [18]. Both generic and brand names of the
selected medication were entered as keywords into the “any of
these words” field in the Advanced Search engine. To exclude
tweets containing advertisements, hyperlinks to external
webpages, and retweets, characters including “rt” for retweets,
“http,” and “.com” were entered into the “none of these words”
field. By eliminating tweets from pharmaceutical companies,
health care marketers, and agencies, Twitter data became more
comparative to the FAERS data. Table 1 describes additional
exclusion criteria in the selection of tweets. The “written in”
field was set so that only tweets in the English language would
be displayed. The time frame was chosen to be from March
2016 to March 2017 in order to correspond with the FAERS
data obtained from CMSA’s SafeRx database. All tweets
displayed were subsequently reviewed to include only those
that described ADRs after consuming the medication. Those
tweets served as the final source for data recording, which
included the username, offending medication, content of the
tweet, and types of ADRs. At the time of data collection, the
number of tweets was benchmarked at 100 for analysis.
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Table 1. Additional exclusion criteria in the collection of tweets.
Exclusion criteria

Examples

ADRsa described a metaphorical narration instead of a true patient experience. “He slept for a whole night like he took 20 Xanax”
ADRs occurred long before the date of tweeting.

“Lipitor gave me muscle aches when I took it 10 years ago”

Tweet was a part of copied lyrics, lines from books, and other forms of liter- “Xanax got me sleeper. Leanin’ by the liter”
ature.
Tweet did not include the 4 minimal requirements to construct a report.

a

Tweets lacking the person who was reporting, the person who experienced the ADR, name of the drug, and the actual ADR.

ADR: adverse drug reaction.

Statistical Analysis
The analysis of ADR data from SafeRx and Twitter included
the following components: calculation of relative frequencies,
examination of ADR distribution, and test for association and
independence. A chi-square test was used to statistically quantify
the difference in ADRs between the FAERS data and Twitter
data. It was appropriate to use the chi-square test as no cell in
the cross-tabulation contained an expected value of 5 or below.
The sample size required to achieve an a priori α<.01 was 96,
and samples from both sources exceeded the threshold. The null
hypothesis (H0) was “there is no significant difference between
FAERS data and Twitter data on common ADRs.” The failure
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to reject H0 would signify that Twitter data were similar to and
independent from the FAERS data. The statistical analysis in
this study was conducted using SAS version 9.4 (SAS Institute
Inc).

Results
US Food and Drug Administration Adverse Event
Reporting System Data Result
A total of 40,539 FAERS ADR reports from March 1, 2016, to
March 31, 2017, were obtained via SafeRx. Table 2 summarizes
the 5 most reported ADRs for each of the 10 drugs.
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Table 2. Five most frequently reported FDA Adverse Event Reporting System adverse drug reactions from March 1, 2016, to March 31, 2017, for each
selected drug on SafeRx.
Drug and the top 5 adverse drug reactions

n (%)

Hydrocodone/acetaminophen (Norco, n=1765)
Ineffectiveness

429 (24.31)

Nausea

371 (21.02)

Fatigue

353 (20.00)

Pain

345 (19.55)

Headache

267 (15.13)

Levothyroxine (Synthroid, n=3728)
Fatigue

881 (23.63)

Ineffectiveness

828 (22.21)

Nausea

733 (19.66)

Headache

664 (17.81)

Diarrhea

622 (16.68)

Prednisone (Deltasone, n=5689)
Ineffectiveness

1423 (25.01)

Fatigue

1332 (23.41)

Dyspnea

1067 (18.76)

Nausea

976 (17.16)

Diarrhea

900 (15.82)

Lisinopril (Prinivil, n=5386)
Ineffectiveness

1243 (23.08)

Fatigue

1172 (21.76)

Diarrhea

1136 (21.09)

Nausea

1062 (19.72)

Dyspnea

773 (14.35)

Amoxicillin (Amoxil, n=797)
Hypersensitivity

328 (41.15)

Fatigue

126 (15.81)

Diarrhea

123 (15.43)

Nausea

121 (15.18)

Rash

99 (12.42)

Gabapentin (Neurontin, n=5734)
Ineffectiveness

1637 (28.55)

Fatigue

1220 (21.28)

Nausea

997 (17.40)

Pain

966 (16.85)

Diarrhea

914 (15.94)

Metformin (Glucophage, n=5109)
Hyperglycemia

1311 (25.66)

Nausea

1111 (21.75)

Ineffectiveness

973 (19.04)

Diarrhea

919 (18.00)
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n (%)
795 (15.56)

Atorvastatin (Lipitor, n=6588)
Type 2 diabetes

4601 (69.84)

Hypersensitivity

586 (8.89)

Fatigue

537 (8.15)

Ineffectiveness

445 (6.75)

Nausea

419 (6.36)

Alprazolam (Xanax, n=2551)
Ineffectiveness

561 (21.99)

Fatigue

548 (21.48)

Nausea

547 (21.44)

Anxiety

451 (17.68)

Headache

444 (17.40)

Amlodipine (Norvasc, n=3192)
Diarrhea

696 (21.80)

Fatigue

682 (21.37)

Ineffectiveness

636 (19.92)

Nausea

611 (19.14)

Dyspnea

567 (17.76)

Twitter Data Result
More than 40,000 tweets containing the drug names as keywords
from March 1, 2016, to March 31, 2017, were obtained from
Twitter’s Advanced Search engine. Although searching on
Twitter yielded an overall large quantity of tweets, ADRs of
some drugs were simply not mentioned in enough tweets. Within
the study period, searching keywords levothyroxine and
Synthroid yielded 50 relevant tweets, keywords alprazolam and
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Xanax resulted in 35 relevant tweets, lisinopril and Prinivil were
found in 33 relevant tweets, and only 3 relevant tweets were
found for atorvastatin and Lipitor. No relevant tweets were
found for keywords amlodipine and Norvasc. Due to the
insufficiency of relevant tweets to meet the benchmark, the final
Twitter data analysis did not include levothyroxine, alprazolam,
lisinopril, atorvastatin, and amlodipine. Table 3 presents the
ADRs reported for the remaining 5 drugs.
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Table 3. Reported adverse drug reactions on Twitter from March 1, 2016, to March 31, 2017, for 5 drugs.
Drugs and adverse drug reactions

Value %

Hydrocodone/acetaminophen
Fatigue

36

Ineffectiveness

22

Pruritus

10

Nausea

9

Mood changes

5

Vivid dreams

3

Insomnia

3

Headache

2

Constipation

2

Dizziness

2

Chest tightness

1

Delusion

1

Hallucination

1

Singultus

1

Inattention

1

Short-term amnesia

1

Sweating

1

Vomiting

1

Prednisone
Insomnia

25

Increased appetite

23

Mood changes

10

Moon face

8

Weight gain

8

Fatigue

5

Muscle weakness

4

Jitteriness

3

Diaphoresis

2

Tachycardia

2

Anxiety

2

Bradycardia

1

Cataracts

1

Xerostomia

1

Dyspnea

1

Heartburn

1

Osteoporosis

1

Stomachache

1

Visual hallucination

1

Thirst

1

Amoxicillin
Hypersensitivity
https://publichealth.jmir.org/2020/3/e19266
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Value %

Rash

16

Ineffectiveness

15

Nausea

8

Diarrhea

5

Fatigue

3

Pruritus

3

Vomiting

3

Stomachache

1

Gabapentin
Drowsiness

31

Fatigue

24

Ineffectiveness

23

Weight gain

8

Dizziness

5

Nausea

2

Blurred vision

1

Dysphasia

1

Confusion

1

Headache

1

Jitteriness

1

Mood changes

1

Vivid dreams

1

Metformin
Nausea

57

Diarrhea

22

Ineffectiveness

5

Fatigue

3

Renal dysfunction

3

Bloating

2

Headache

2

Hypersensitivity

1

Heartburn

1

Hypoglycemia

1

Mood changes

1

Vomiting

1

Drug and Adverse Drug Reaction Matching
The process was completed through consolidating the ADRs
reported in the Twitter dataset to match the top 5 ADRs from
SafeRx. Following the matching, a chi-square test was
performed to test nonsignificant differences in the relative
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frequencies of an ADR between FAERS data and Twitter data.
In order to demonstrate the similarity of Twitter’s ADR profile
with that of FAERS, one should fail to reject H0 according to
the P value from the chi-square test. Table 4 shows matched
ADRs between the two data sources, relative frequencies of
ADRs of each drug, and the results of chi-square test.
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Table 4. Matched adverse drug reactions and chi-square test results for 5 drugs.
Relative frequencies, FAERSa data (%)

Relative frequencies,
Twitter data (%)

Chi-square

P value

Ineffectiveness

24.31

22.00

0.3

.60b

Nausea

21.02

9.00

5.3

.02

Fatigue

20.00

36.00

14.7

<.001

Headache

15.13

2.00

13.2

<.001

Fatigue

23.41

5.00

18.8

<.001

Dyspnea

18.76

1.00

47.0

<.001

Hypersensitivity

41.15

46.00

0.9

.35b

Diarrhea

15.43

5.00

7.9

.005

Nausea

15.18

8.00

3.8

.05b

Fatigue

15.81

3.00

11.8

<.001

Rash

12.42

16.00

1.0

.31b

Ineffectiveness

28.55

22.00

2.1

.15b

Fatigue

21.28

23.00

0.2

.68b

Nausea

17.40

2.00

16.4

<.001

Nausea

21.75

57.00

70.1

<.001

Ineffectiveness

19.04

5.00

12.7

<.001

Diarrhea

18.00

22.00

1.1

.30b

Fatigue

15.56

3.00

11.9

<.001

Drug and adverse drug events
Hydrocodone/acetaminophen

Prednisone

Amoxicillin

Gabapentin

Metformin

a

FAERS: US Food and Drug Administration Adverse Event Reporting System.

b

Indicates a P value above .05, leading to the failure of rejecting the null hypothesis and indicating that there is no difference in ADR frequency reported
between FAERS and Twitter.

Discussion
Principal Findings
Among the 5 drugs in the final analysis, a number of Twitter
ADR relative frequencies were not significantly different from
those of FAERS ADRs. For metformin, diarrhea was one of the
side effects. As no significant difference was detected between
FAERS and Twitter data on diarrhea (P=.30), it showed that
Twitter ADR reports could be further studied for their use as a
complementary
ADR
dataset.
In
the
hydrocodone/acetaminophen group, there were no significant
differences in ineffectiveness between sources (P=.60).
Gabapentin was shown to comparatively result in ineffectiveness
and fatigue according to FAERS and Twitter (P=.15 and P=.67,
respectively). Three ADRs of amoxicillin, hypersensitivity,
nausea, and rash, shared similar profiles on FAERS and Twitter
(P=.35, P=.05, and P=.31, respectively).
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ADRs remain one of the leading causes for preventable hospital
admissions, reduced quality of life, increased financial burdens
in the society, and mortality [19]. Prevention relies on adherence
to evidence-based medicine, monitoring, medication therapy
management, and pharmacogenomic testing [20]. Management
of ADRs should emphasize effective prevention and timely
detection, yet the current ADR reporting mechanism has shown
delays in detection [21]. The cause for delays is multifactorial.
Consumers might not know about such a reporting system, and
the reporting steps could be troublesome. Further, as clinicians
and patients are not required to report ADRs, many could be
underreported. Social media and online resources have been
proposed as additional resources for pharmacovigilance. In
2017, MacKinlay et al [22] evaluated ADRs of 3055 drugs on
Twitter and found that Twitter had up to 72% precision of ADR
detection. By extracting ADRs of erlotinib, nivolumab, and
pembrolizumab through social health networks, Nikfarjam et
al [23] detected that social media ADRs were comparable and
7 months ahead of ADRs from literature reports. Along with
JMIR Public Health Surveill 2020 | vol. 6 | iss. 3 | e19266 | p. 9
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numerous major publications on validating ADR reports across
different social media platforms, Hoang et al [24] took a step
further and incorporated content authenticity and user credibility
to improve ADR detection on Twitter. With more advanced
technology for data mining and ADR detection, social media
can serve as an additional channel for monitoring ADRs.
In this study, 10 drugs were identified, and ADR reports of these
drugs on Twitter were retrospectively obtained by searching for
tweets containing the drug names that mentioned ADR
experiences. While adopting comparative methods used in
previous studies, this study specifically focused on the 10 most
commonly prescribed drugs to investigate if discrepancies
existed pursuant to different drugs. Based on the results of this
study, FAERS data and Twitter data showed some similar ADR
profiles for hydrocodone/acetaminophen, amoxicillin,
gabapentin, and metformin. In the data collection process,
levothyroxine, alprazolam, lisinopril, and atorvastatin did not
appear as keywords in sufficient tweets from March 1, 2016,
to March 31, 2017. A possible explanation of the low number
of tweets is the demographics of patients taking these
medications. Atorvastatin, a lipid-lowering agent, is usually
initiated for elderly patients, as are the antihypertensive agents
lisinopril and amlodipine. Individuals aged 50 to 64 years and
those older than 65 years represented 21% and 10% of all
Twitter users, respectively [16]. Fewer Twitter users in these
age ranges could potentially explain the low number of tweets
for those drugs. The number of reports of these 3 drugs on
FAERS further demonstrates that the lack of tweets was due to
fewer users, as atorvastatin, lisinopril, and amlodipine had 6588,
5386, and 3192 reports on FAERS. Other social media–based
studies have also experienced this challenge and achieved
opposite conclusions due to inactivity for most of the drugs
studied on social media [25,26]. Nevertheless, data from the
remaining drugs indicates the potential role of Twitter as a
complementary source of ADR reporting to FAERS.
The similarities observed for some ADRs between Twitter and
FAERS data were disparate across the individual drugs studied.
This variability further suggests that patients’ actual experiences
with medications are not being shared with their providers or
that providers have not reported these experiences to national
ADR repositories at a similar rate. Moreover, the insufficiency
of tweets for some drugs may indicate that social media ADR
reporting should consider drug classes and the demographics
of patients taking them. One recommendation is to further
investigate social media ADR reporting for drugs that are
consumed by a population that represents a large share of social
media users and drugs that require early ADR detection.
In addition to being a supplementary data source for
pharmacovigilance services, social media can also serve as a
resource for pharmaceutical companies, regulatory bodies,
researchers, health care professionals, patients, and
policymakers. In this study, ineffectiveness appeared as an ADR
for hydrocodone/acetaminophen, gabapentin, and metformin
on both data sources. Gabapentin, for example, takes time to
exert its full effect in controlling neurological pain. As 23.00%
of Twitter ADRs and 28.55% of FAERS ADRs for gabapentin
were ineffectiveness, it should encourage prescribers and
pharmacists to consult patients on the time lag between taking
https://publichealth.jmir.org/2020/3/e19266
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the medication and seeing its effect. This study result should
also prompt patient education on regular monitoring and diet
adjustment when managing diabetes, as ineffectiveness for an
antidiabetic drug, metformin, was 19.04% and 5.00% of all
ADRs on FAERS and Twitter, respectively. Data mining to
track ineffectiveness for hydrocodone/acetaminophen may offer
a potential avenue for regulatory bodies in examining opioid
use patterns.

Limitations
This study does have two prominent limitations: sample size
and search methodology. Among multiple social media
platforms, only Twitter was selected as the data source. Despite
Twitter’s users being from multiple age groups, patients may
choose to share their ADR experiences on other sites such as
Facebook, Instagram, Reddit, and online forums, which
prevented this study from examining social media data across
different platforms. Additionally, due to Twitter’s privacy
setting, private tweets are not searchable, which can reduce the
number of tweets for data collection. The sample size of tweets
obtained for the drugs was relatively small compared with that
of FAERS reports from March 1, 2016, to March 31, 2017. The
sample size could be largely increased in future studies as
Twitter contains a large collection of tweets. During the search
process, the keywords hydrocodone/acetaminophen and Norco
yielded more than 100 tweets in the time period, which could
potentially improve the accuracy of Twitter ADR data. However,
there was a lack of relevant tweets for 4 of the 10 drugs, even
with the benchmark of 100 tweets. This situation could
potentially be resolved by extending the time frame to more
than 1 year; however, the extent of sample size improvement
might not be significant given the low number of social media
users when studying specific drugs such as atorvastatin and
amlodipine.
Regarding the search mechanism, only one common brand name
per drug was used to search for tweets, yet many drugs have
multiple brand names. Lisinopril is sold under the brand names
Prinivil and Zestril, and levothyroxine has brand names
Synthroid, Levoxyl, and Thyrax. Using only one brand name
in the study could limit the number of tweets obtained in this
study, as patients might have shared their ADRs by using the
brand names that were not included in this study. Other
challenges to gathering all tweets through keywords include
typographical errors, abbreviations, and unstructured lexicons.
Furthermore, social media intrinsically bears a limitation in
terms of patient follow-up. So far, research methodology
involving social media pharmacovigilance has yet to be capable
of investigating the causes of ADRs, the consequences of ADRs,
and the actions taken to resolve ADRs. Some challenges are
being tackled by computational technologies. For example, text
normalization and classification through machine learning have
been investigated by Sarker et al [27], and they offered insights
into processing text data on social media. Other challenges of
social media ADR reporting may continue to be barriers for
taking full advantage of this data source.
Although social media cannot replace professional reporting
systems such as FAERS at this stage, studies including this
analysis have indicated the role of social media as a tool for
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early detection and a reporting system for mild symptoms. To
demonstrate the accuracy and usability of social media ADR
data in complementing FAERS, future studies may benefit by
using a larger sample of data, including specific drugs, and
assessing multiple social media platforms. It is also important
to apply technology, along with structured reporting systems,
to avoid arbitrary entries to better provide health care
professionals, regulatory bodies, patients, and pharmaceutical
companies with robust ADR data.

Zhou & Hultgren

Conclusion
While the use of Twitter as an ADR reporting platform has
limitations, should be considered as a unique and complementary
source of information rather than a validation tool of an existing
ADR database. Future research should focus on validating
Twitter and other social media platforms using involving larger
sample sizes and different medications. Additionally, evaluating
the types of ADRs on social media that share the most similarity
with those on FAERS would be helpful to promote effective
use of this source of information.
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